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Executive Summary 2011
The annual publication of the Massachusetts STD, HIV/AIDS, and Viral Hepatitis
Surveillance Report provides an occasion to reflect upon trends in these diseases
within the Commonwealth of Massachusetts.
In 2011, the following trends existed with regard to the three most commonly reported
bacterial STIs in Massachusetts:
• Infectious syphilis (primary, secondary, and early latent syphilis) incidence 
rates continued to increase yearly – a trend which began in the last 
quarter of 2007. Although infectious syphilis remains relatively rare 
overall, the disease remained at epidemic levels among men who have 
sex with men.
• Gonorrhea incidence decreased in 2011 by 6%. Gonococcal disease 
primarily remains concentrated within non-white populations from major 
urban centers.
• Incident chlamydia infections continue to increase with more provider 
screening. Increased case reporting is reflective of increased electronic 
laboratory reporting, and/or access to screening with more sensitive 
laboratory testing, perhaps not true increases in incidence of disease. 
Moreover, recent research has revealed gaps in our understanding of 
what proportion of chlamydia cases will progress to complications such 
as epididymitis, pelvic inflammatory disease, ectopic pregnancy, infertility, 
or chronic pelvic pain.1
Regarding HIV/AIDS, notable trends in 20102 included the following:
• Newly diagnosed infections and deaths continued to decline but the 
actual number of persons known to be living with HIV/AIDS in 
Massachusetts increased to over 17,000 in 2010 and over 18,000 in 
2011 because survival continued to improve.
• Similar to other sexually transmitted infections, black and Hispanic/Latino 
residents have higher rates of HIV infection compared to white residents.
• Male with male sex remains the single largest identified exposure mode 
among newly diagnosed HIV cases.
With regard to viral hepatitis, we observed the following trends in 2011:
• Chronic confirmed cases of hepatitis B continued to decline, a trend 
due in large part to increasing levels of immunity against hepatitis B in 
adults at risk of infection and almost universal immunization of children 
against hepatitis B.
• There has been an overall decline in the number of newly diagnosed 
hepatitis C cases reported in Massachusetts since 2004. However, at 
approximately 79 cases per 100,000 population in 2011, hepatitis C 
remains one of the highest volume reportable infections. There continue 
to be a high number of hepatitis C cases reported among adolescents 
and young adults, indicating ongoing transmission among young people 
injecting drugs in the state.
1 Gottlieb et al. Summary: the natural history and immunobiology of chlamydia trachomatis genital infection and 
implications for chlamydia control. Journal of Infectious Diseases 201:S190-204, 2010.
2 Due to reporting delays related to site-specific reporting issues, all HIV/AIDS data reflect HIV diagnosed through 2010.
Highlighted on pages 15–22 are trends within special populations disproportionally 
affected by STIs, HIV/AIDS, and/or viral hepatitis. Massachusetts data are reflective of 
a number of national trends among women, minorities (both sexual and racial/ethnic 
minorities), and youth. Where we differ is in the fact that our surveillance has revealed
some increasing gaps among certain racial/ethnic and sexual minorities in reported
STIs. It remains to be determined whether this reflects improved access to care leading
to more screening and identification of infection, or true increases in infection within 
certain minority populations. Improvements in reporting systems, which provide more
complete information on other possible risk and protective associations, are critical for
improving our understanding of disparities in reportable diseases. 
The focus of this annual surveillance report is necessarily on diseases reportable 
to the state and cannot address all determinants of health. However, it should be 
recognized that sexually transmitted infections, including HIV/AIDS and viral 
hepatitis, occur at the nexus of individual human behavior, community risk, clinical 
diagnosis and treatment, and public health prevention and control. The intended 
audience for this annual surveillance report includes the clinicians and the laboratory
professionals who report these cases, as well as the community organizations, local
public health departments, policymakers, and researchers who are interested in the
sexual health and well-being of residents of the Commonwealth of Massachusetts.
We welcome feedback, and invite you, the reader, to begin by thinking in terms of
disease statistics, but end by acting in terms of health promotion.
Brenda Cole, MEd, Director, Division of STD Prevention
Daniel Church, MPH, Coordinator, Adult Viral Hepatitis Prevention
Dawn Fukuda, MPH, Director, Office of HIV/AIDS
Katherine Hsu, MD, MPH, Medical Director, Division of STD Prevention and
HIV/AIDS Surveillance
Alfred DeMaria, Jr., MD, Medical Director and State Epidemiologist, Bureau of 
Infectious Disease 
Kevin Cranston, MDiv, Director, Bureau of Infectious Disease Prevention, Response
and Services
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There were 22,869 reported chlamydia 
infections in Massachusetts in 2011. Chlamydia
infection is widely distributed in Massachusetts.
The geographic distribution of cases within the
state in 2011 was similar to 2010.
Additional information about chlamydia and
other STIs is available online at
www.mass.gov/dph/cdc/std.
The overall Massachusetts chlamydia 
infection rate is 349 per 100,000. The highest
incidence rates of reported chlamydia 
infections are in large urban areas around
Boston and Springfield.
Throughout the state, the majority of cities 
and towns fall into the 50 to 200 cases per
100,000 population range.
The total number of reported chlamydia infection
cases in Massachusetts has more than doubled
in the past ten years, from 10,924 in 2002 to
22,869 in 2011. 
There was an 8% increase in the number of
cases reported in 2011 compared to 2010.
Of the total reported cases in 2011, 7,024 were
among men and 15,823 were among women.
The greater number of chlamydia cases among
women is a combined effect of increased 
incidence and a higher level of screening as
compared to men.
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In 2011, the incidence of reported chlamydia 
infection in Massachusetts among adolescents
(ages 15-19) and young adults (ages 20-24) 
exceeded 1,300 and 2,000 per 100,000, 
respectively. Please note, caution should be 
used in comparing STI rates from the period 
2002 to 2009 to rates from 2010 and 2011 as 
the former are calculated with US Census 
2000 data and the later US Census 2010. 
See section IV on page 24, for further detail.
Historically, members of communities of color
have been disproportionately affected by STIs. 
In 2011, compared to the white population, the 
incidence rate of reported chlamydia infection in
Massachusetts was ten times higher in the black
and five times higher in the Hispanic/Latino 
population. Disparities in the rate of chlamydia
infection in Massachusetts have decreased in 
recent years. Please note that cases with 
unknown race/ethnicity are no longer included in
this analysis, see section IV on page 24 for further
detail. Since 2008, changes in electronic reporting
of laboratory results indicating STI cases to
MDPH resulted in an increased proportion of 
STI cases being categorized as “other” race.
Thus, as of 2008, increases in the rate of STIs in
the “other” category may be related to electronic
reporting rather than increase in incidence. 
INFERTILITY PREVENTION PROJECT, PERCENT POSITIVE FOR 
CHLAMYDIA INFECTION, MASSACHUSETTS, 2011
Since 1997, the Division of STD Prevention has participated in a Centers for Disease Control and
Prevention (CDC)-funded Infertility Prevention Project. The goal of this project is to reduce infertility
and other health consequences of chlamydia infection through increased screening and treatment
of women who are at higher risk for infection.
In 2011, as part of the Infertility Prevention Project, 17,606 specimens were tested for chlamydia
infection. Test results from participating sites have yielded the following: 
PERCENT POSITIVE FOR CHLAMYDIA TRACHOMATIS
SITE TYPE (number tested) FEMALES MALES
School-Based Health Centers (n=1,023) 8% 9%
Correctional Facilities (n=2,366) 4% 8%
Family Planning Clinics (n=11,053) 6% 16%
STD Clinics (n=3,164) 5% 6%
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The overall number of reported cases of 
gonorrhea in Massachusetts in 2011 was 
2,347 cases, a 6% decrease from the 
previous year. Although gonorrhea is widely
distributed in Massachusetts, cases are 
more prevalent in urban locations.
Additional information about gonorrhea and
other STIs is available online at
www.mass.gov/dph/cdc/std
The overall Massachusetts gonorrhea 
infection rate is 36 per 100,000. The highest
incidence rates of reported gonorrhea are 
in Provincetown, Brockton, Boston and
Springfield.
The highest concentration of cases is in the
eastern part of the state.
From 2002 to 2011, the number of reported
gonorrhea cases fluctuated with both year-
to-year increases and decreases over the 
ten-year period. Overall, there are fewer 
gonorrhea cases reported in recent years; 
the number of cases decreased by 26% from
2002 (N=3,191) to 2011 (N=2,347). 
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From 2002 to 2009, the male-to-female ratio 
of reported gonorrhea cases ranged from 0.9 
to 1.2. The male-to-female ratio peaked at 
1.5 in 2010 and then decreased to 1.2 in 2011
(1.2 =1,277 male cases/1,069 female cases).
From 2002 to 2011, the rate of gonorrhea 
incidence per 100,000 was highest among young
adults ages 20 to 24 years (155 per 100,000). In
2011, the gonorrhea incidence rate among young
adults (ages 20 to 24 years old) was four times
the state-wide incidence rate; among 25 to 29
year olds (106 per 100,000) it was three times the
state-wide incidence rate. Please note, caution
should be used in comparing STI rates from the
period 2002 to 2009 to rates from 2010 and 2011
as the former are calculated with US Census
2000 data and the later US Census 2010. 
See section IV on page 24, for further detail.
In 2011, in Massachusetts, the reported 
gonorrhea incidence rate was 12 times higher 
in the black population (175 cases per 100,000)
and three times higher in the Hispanic/Latino 
population (44 cases per 100,000) compared to
the white population (15 cases per 100,000). 
In 2008, changes in electronic reporting of 
laboratory results indicating STI cases to MDPH 
resulted in an increased proportion of STI cases
being categorized as “other” race. Thus, as of
2008, increases in the rate of STIs in the “other”
category may be related to electronic reporting.
Please note that cases with unknown race/
ethnicity are no longer included in this analysis,
see section IV on page 24 for further detail.
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In 2011, there were 500 reported infectious
syphilis cases (primary, secondary, and early 
latent) in Massachusetts. Although infectious
syphilis cases have been reported in almost 
all counties, 39% of the cases (196) were 
reported in Suffolk County. Compared to last
year, increases of 129% and 89% were seen in 
Hampden and Barnstable Counties, respectively.
Additional information about infectious syphilis is
available online at www.mass.gov/dph/cdc/std.
In 2011, Bristol, Essex, Franklin, Hampshire,
Middlesex and Plymouth Counties had syphilis
incidence rates of less than five cases per
100,000 population. Barnstable, Dukes, 
Norfolk and Worcester counties had rates 
between five and ten cases per 100,000 
population. Hampden County had a rate 
between 10 and 15 cases per 100,000. 
Berkshire and Nantucket Counties had a 
rate of zero. Suffolk County had the highest
syphilis rate at 27 cases per 100,000 
population.
In Massachusetts, the male-to-female ratio of 
infectious syphilis cases increased from 5 to 1 
in 2002, to 11 to 1 in 2011. This shift reflects 
an increase in the number of infectious syphilis
cases diagnosed in men who have sex with
men. This trend has also been observed in other
regions of the United States. Although the 
number of female cases is much smaller than
male, it has more than doubled in the past four
years from 2008 (N=18) to 2011 (N=46).
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In contrast to chlamydia infection and gonorrhea,
which tend to occur more frequently among 
adolescents and young adults, the majority of 
infectious syphilis cases are reported in 
individuals age 30 years and above. However, 
in recent years, the proportion of cases among
people in their twenties has increased and the rate
of syphilis infection per 100,000 was highest
among 20-24 and 25-29 year olds in 2010 and
2011. Please note, caution should be used in 
comparing STI rates from the period 2002 to 2009
to rates from 2010 and 2011 as the former are 
calculated with US Census 2000 data and the later
US Census 2010. 
See section IV on page 24, for further detail.
In 2011, the reported infectious syphilis incidence
rate was five times higher in the black population
(26 cases per 100,000) and three times higher in
the Hispanic/Latino population (17 cases per
100,000) compared to the white population 
(5 cases per 100,000). Please note that cases
with unknown race/ethnicity are no longer 
included in this analysis, see section IV on page
24 for further detail.
SYPHILIS IN MEN THAT HAVE SEX WITH MEN (MSM)
In Massachusetts, MSM represent a higher-risk group for infectious syphilis. Of the 500 infectious
syphilis cases in 2011, 363 (73%) were reported in MSM. Forty-two percent (N=151) of the MSM
with infectious syphilis disclosed that they were co-infected with HIV. Forty percent (N=144) of the
infectious syphilis cases in MSM were reported in Suffolk County. 
Transmission of syphilis can occur between men through unprotected oral and anal sex. Additional
information and resources regarding MSM and STIs is available online at:
http://www.mass.gov/eohhs/gov/departments/dph/prog-a-j/bcdc/factsheets.html 
HI
V/
AI
DS
HIV/AIDS
Page 9
Of the 351 cities and towns in Massachusetts,
194 (54%) had at least one newly diagnosed
HIV infection reported from 2008 to 2010. 
The majority of newly identified HIV infections
were reported in large urban areas.
HIV infection case and incidence data by 
city and town are available online at
www.mass.gov/dph/cdc/aids. Additional 
information is available through the MDPH
HIV/AIDS Epidemiologic Profile at the same
weblink.
Of those cities and towns where HIV infections
were diagnosed within the three-year period
2008 to 2010, the majority (72%) had rates 
of under 10 per 100,000 population.
Provincetown had the highest rate of HIV 
infection diagnosis at 358 per 100,000 
population.
In 2010, there were 652 newly diagnosed HIV 
infections and 232 deaths among people reported
with HIV/AIDS in Massachusetts.
Newly diagnosed HIV infections and deaths
among people with HIV/AIDS continue to 
decline each year, but because newly diagnosed
infections continue to exceed the number of
deaths annually, the number of people known
to be living with HIV/AIDS in Massachusetts 
increased from 13,095 on December 31, 2001 to
17,645 on December 31, 2010. 
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From 2008 to 2010, of the 2,024 newly diagnosed
HIV infections in Massachusetts, 1,485 (73%)
were in men and 539 (27%) were in women. 
Most of the newly diagnosed HIV infections in
men were in white men, whereas the majority of
newly diagnosed HIV infections in women were 
in black women.
From 2008 to 2010, the primary exposure 
mode reported among newly diagnosed cases
of HIV infection in Massachusetts was male-
to-male sex at 41%, followed by heterosexual
sex (13%), presumed heterosexual sex (11%),
and injection drug use (9%). Twenty-three 
percent of newly diagnosed cases were 
reported without adequate risk information.
Since the mid-1990s, Massachusetts 
experienced a dramatic reduction in mother-
to-child transmission of HIV infection. From
2001 to 2010, the number of HIV-infected 
newborns identified ranged from zero (in 2006
and 2008) to five (in 2002). The decline is 
attributed to improvements in HIV screening
during pregnancy and the treatment of HIV-
infected women with anti-retroviral therapy.
However, every case of mother-to-child 
transmission remains a sentinel event 
mandating investigation to identify if new 
systems can be put in place to assure maximum
efforts to prevent vertical transmission.
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The number of confirmed cases of chronic 
hepatitis B reported to Massachusetts has been
declining since 2005. In 2011, 538 confirmed
chronic cases were reported. This number is
likely to increase due to continued processing 
of case reports and case confirmation. Even so,
there is an overall downward trend to both 
confirmed and probable cases of hepatitis B 
infection (data not shown), due in large part 
to increasing levels of immunity against 
hepatitis B in adults at risk of infection and 
almost universal immunization of children
against hepatitis B.
Sixteen confirmed cases of acute hepatitis 
B were identified in 2011.Confirmation of 
acute infection requires additional information,
including specific laboratory test results and
symptom information. 
It is recommended that pregnant women be
screened for hepatitis B during pregnancy to
allow case management to begin early and 
prevent transmission of the virus to infants. 
Since 2007, the Perinatal Hepatitis B Program
has partnered with local public health programs 
to increase identification of household and 
sexual contacts of hepatitis B surface antibody
(HBsAg)-positive pregnant women in an effort 
to reduce the risk of maternal-child transmission
of hepatitis B. 
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Due to enhanced surveillance focused on
identifying pregnant women who are hepatitis 
B positive, a large number of the hepatitis 
B cases identified and reported in 2011 were in
women between the ages of 25 and 44 years.
While efforts are made to identify infection
among the household and sexual contacts 
of these women, there are many barriers to 
getting those partners tested.
Most newly diagnosed cases of chronic hepatitis
B are in people living in urban areas such as
Boston, Worcester, Lowell and Springfield. 
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There has been an overall decline in the number
of newly diagnosed hepatitis C infection cases
reported in Massachusetts since 2004. However,
the overall number of cases reported remains
very high with 7,000 to 10,000 newly diagnosed
probable and confirmed cases reported to
MDPH annually since 2002. There are hepatitis
C cases reported to MDPH for 2011 that have
yet to be fully processed, so this number is likely
to increase. Hepatitis C remains one of the 
highest volume infectious diseases reported 
in Massachusetts. 
Improvements in surveillance have also allowed
for better identification of acute cases of hepatitis
C. Twenty-seven acute cases were confirmed 
in 2011. Identification of acute cases requires 
information on hepatitis A and B test results,
serum liver enzyme tests and symptoms. 
One-hundred and thirty-two cases of hepatitis 
C reported in 2011 matched the acute case 
definition, but hepatitis A or B laboratory results
were not available to rule out other causes of
viral hepatitis. Acute cases of hepatitis C are 
reported in CDC’s annual summary of notifiable
diseases, while chronic hepatitis C is not.
The age distribution of hepatitis C cases 
reported in Massachusetts has changed 
between 2002 and 2011. In 2002 the reported
cases were distributed in a bell-shaped curve
with the age peak between the ages of 44 
and 50 years. In 2011, the reported cases 
were distributed in a bi-modal curve with one
peak at 25 years of age and a second at 
51 years. 
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More hepatitis C cases reported in 2011 are
identified in males than in females in almost all
age groups, except the 15 to 24 year age
group, where the number of females is slightly
higher than males.
Cases of hepatitis C are reported in communities
across Massachusetts, with more cases being
identified in people living the urban areas of
Boston, Worcester, and Springfield. 
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In 2011, 68% of reported chlamydia infection
cases and 44% of reported gonorrhea cases
were in adolescents and young adults (ages
15-24).
From 2008 to 2010, reported newly diagnosed
HIV infections among adolescents and young
adults in Massachusetts had the following racial/
ethnic distribution: black (non-Hispanic) (34%),
white (non-Hispanic) (32%), Hispanic/Latino
(30%), and other (4%).
STDs IN ADOLESCENTS AND YOUNG ADULTS
Compared to older adults, sexually active adolescents and young adults are at higher risk for 
acquiring STIs for a combination of behavioral, biological and cultural factors. The higher 
prevalence of STIs among adolescents also may reflect multiple barriers to accessing quality STD
prevention services, including lack of insurance or other ability to pay, lack of transportation, 
discomfort with facilities and services designed for adults, and concerns about confidentiality.
(Source: CDC. Sexually Transmitted Disease Surveillance, 2010. Atlanta: U.S. Department of
Health and Human Services; 2011.)
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From 2008 to 2010, in Massachusetts, the 
primary mode of exposure for reported, newly 
diagnosed HIV infection cases in adolescents
and young adults was male-to-male sex (59%),
followed by presumed heterosexual sex (9%),
heterosexual sex (7%), and injecting drug 
use (4%). Fourteen percent of adolescents 
and young adults were reported with no risk 
information.
The Youth Risk Behavior Survey (YRBS) is performed biennially among a national
sample of 9th-12th grade students. A review of data provided from the Massachusetts
YRBS over the past two decades indicates that three markers of risky youth sexual
behavior (ever having had sex, first sex before age 13 years, and four or more lifetime
sexual partners) reached all-time lows in 2003 (respectively 41%, 5%, and 10%), and
after slight increases of potential concern in 2009, returned to similar lows in 2011 (to
42%, 4%, and 11% in 2011). In contrast, two markers of protective sexual behaviors,
use of condoms at last sex and being taught about HIV/AIDS in school, have shown
declines from previous gains (respectively 58% in 2011 down from 65% in 2005, and
84% in 2011 down from 93% in 2005).
SEXUAL BEHAVIORS AMONG MASSACHUSETTS HIGH SCHOOL 
STUDENTS, 2003–2011
AFFIRMATIVE RESPONSES (percent)
2003 2005 2007 2009 2011
Lifetime sexual intercourse 41 45 44 46 42
Sexual intercourse before age 13 5 5 6 5 4
Four or more lifetime sexual partners 10 13 12 13 11
Condom use at last sexual intercourse 57 65 61 58 58
Taught in school about AIDS or HIV 92 93 89 87 84
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Unlike gonorrhea, reported chlamydia infection
in Massachusetts is more common in women.
From 2002 to 2011, the number of chlamydia
cases in women increased by 93%, in part 
due to increased adoption of routine screening
by Massachusetts healthcare providers, as
recommended by the Centers for Disease
Control and Prevention.
While the male-to-female ratio of gonorrhea
cases is about 6:5, women are over-represented
among chlamydia cases by a ratio of 2.5:1.
The greater number of chlamydia cases in
women is attributable in part to increased 
screening in women as compared to men.
STDs AND WOMEN
Complications of STIs are greater and more frequent among women than men due to two primary
factors. First, biologically, women are more likely than men to become infected if exposed. Second,
STIs are more likely to remain undetected in women, resulting in delayed diagnosis and treatment,
and ultimately more untreated infections leading to complications. (Source: The Hidden Epidemic,
Institute of Medicine, National Academy Press, Washington, D.C., 1997.)
Untreated STIs in women can lead to serious health consequences, including pelvic inflammatory
disease, infertility, ectopic pregnancy and cervical cancer.
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From 2008 to 2010, the exposure modes for 
the 539 newly diagnosed HIV cases reported 
in women in Massachusetts were attributed to 
presumed heterosexual sex (42%), heterosex-
ual sex (32%), injection drug use (12%), and
other exposure modes (1%). Thirteen percent 
of women were reported with no identified risk
for HIV exposure.
From 2008 to 2010, 49% of women reported
with HIV infection diagnoses were born outside
of the U.S. For men diagnosed from 2008 to
2010, only 24% were born outside of the U.S.
Eighty-five percent of women diagnosed with
HIV infection who were born outside of the 
U.S. were born in regions of the world where
heterosexual sex is the predominant mode 
of transmission of HIV infection.
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Although communities of color represent only
24% of the total Massachusetts population,
these communities bear a disproportionate
burden of STIs. In 2011, 53% of the reported
infectious syphilis cases, 59% of the reported
gonorrhea cases, and 63% of the reported 
chlamydia infection cases occurred in 
individuals from communities of color.
From 2008 to 2010, the racial/ethnic distribution
of reported newly diagnosed HIV infections in
Massachusetts was: white (non-Hispanic)
(39%), black (non-Hispanic) (33%), Hispanic/
Latino (25%), and other/unknown (3%).
RACIAL/ETHNIC DISPARITIES IN STD RATES
As stated in the 2010 Sexually Transmitted Disease Surveillance Report from the Centers for 
Disease Control and Prevention (CDC), national surveillance data show higher rates of reported
STIs among some racial or ethnic minority groups when compared with rates among white 
residents. Race and ethnicity in the United States are risk markers that correlate with other more
fundamental determinants of health status such as poverty, unemployment, low educational 
attainment, access to quality health care, and living in communities with high prevalence of STDs.
“Acknowledging the inequity in STD rates by race or ethnicity is one of the first steps in empowering
affected communities to organize and focus on this problem.” (Source: CDC. Sexually Transmitted
Disease Surveillance, 2010. Atlanta: U.S. Department of Health and Human Services; 2011.)
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In Massachusetts, in 2010, the prevalence rate
of people living with HIV/AIDS was highest
among the black (non-Hispanic) and Hispanic/
Latino populations. As compared to the white
(non-Hispanic) population, the rate of people 
living with HIV/AIDS was 11 times higher among
the black (non-Hispanic) population and eight
times higher among the Hispanic/Latino 
population.
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In 2011, 363 infectious syphilis cases were 
reported in MSM in Massachusetts, of which
144 (40%) were in Suffolk County. 
From 2002 to 2011, MSM have accounted for 
the majority of infectious syphilis cases in 
Massachusetts, ranging from 57% in 2002 to
73% in 2011. During this time period the number
of reported cases among MSM increased by 
over three times, from 118 to 363.
In 2011, 52% of reported infectious syphilis 
cases in MSM were reported among white 
individuals, 16% among black, 19% among 
Hispanic/Latino, 10% among individuals of other
race/ethnicity, and 4% among individuals with 
unknown race/ethnicity. The median age of the
cases was 36 years, the same median age of 
the previous year.
STDs AND HIV IN MEN WHO HAVE SEX WITH MEN
Notifiable disease surveillance data on syphilis and data from the National Gonococcal Isolate
Surveillance Project suggest that some STDs are increasing in MSM, including men who 
have sex with both men and women. Because STIs and the behaviors associated with acquiring
them increase the likelihood of acquiring and transmitting HIV infection, the rise in STIs 
among MSM may be associated with the increase in HIV diagnosis among MSM. (Source: CDC.
Sexually Transmitted Disease Surveillance, 2010. Atlanta: U.S. Department of Health and Human
Services; 2011.)
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In 2011, 42% of the reported infectious
syphilis cases in MSM occurred in individuals
who reported that they were HIV-positive.
Among males, the proportion of reported HIV 
infection cases with male-to-male sex as the 
reported mode of exposure increased from 44%
in 2001 to 55% in 2010.
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SUMMARY OF STRENGTHS AND LIMITATIONS OF DATA
HIV/AIDS Case Data
• Collected by MDPH 
Bureau of Infectious 
Disease, HIV/AIDS 
Surveillance Program.
• Reportable statewide.
• All licensed healthcare 
providers are required 
by law to report. 
• HIV infection and 
AIDS cases are reported 
by name.
• Individuals diagnosed 
out of state have been 
excluded in analysis.
• Statewide reporting, 
population-based.
• Risk information is 
available. 
• Completeness of 
reporting is high.
• Comparable with other 
states.
• Under-reporting 
(10%–15%) hampers 
interpretation of HIV/AIDS
case data.
• Not all HIV/AIDS cases 
are reported at time of 
diagnosis (reporting lag).
• HIV/AIDS data may be 
incomplete because 
some HIV-infected people
may not have been 
tested or have entered 
care.
STD Case Data
• Collected by MDPH 
Bureau of Infectious 
Disease, Division of 
STD Prevention. 
• Reportable statewide.
• All labs and healthcare 
providers are required by 
law to report STIs 
(including syphilis, 
gonorrhea, chlamydia 
infection, lymphoma 
granuloma venereum, 
chancroid, granuloma 
inguinale, neonatal 
herpes infection)
• Statewide reporting, 
population-based.
• Comparable with other 
states.
• Enhanced reporting of 
positive laboratory results.
• Under-reporting of up to 
10% of STD cases.
• Race/ethnicity is missing 
in 30% of gonorrhea and 
chlamydia infection cases.
• Bias is introduced for 
some STDs, such as 
chlamydia infection, 
where screening of 
asymptomatic persons 
occurs more frequently 
in women than in men.
Viral Hepatitis Case Data
• Collected by MDPH 
Bureau of Infectious 
Disease, Office of 
Integrated Surveillance 
and Informatics Services.
• Reportable statewide.
• All laboratories and 
healthcare providers are 
required to report 
laboratory indicators of 
hepatitis B and C 
infection.
• Statewide reporting, 
population-based.
• Enhanced reporting of 
acute cases, hepatitis B 
cases in child-bearing 
aged women and children
and hepatitis C cases 
among youth ages 15–25.
• Race data are missing in 
19% of confirmed acute 
hepatitis B and 10% of 
confirmed hepatitis C 
cases; ethnicity data are 
missing in 38% of acute 
hepatitis B and 64% of 
confirmed hepatitis C 
cases.
• Risk history data is 
missing in a majority of 
reported hepatitis B and 
C cases.
Description
Strengths
Limitations
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INTERPRETING STD, HIV/AIDS AND VIRAL HEPATITIS DATA
All viral hepatitis data reported are current as of July 24, 2012, all HIV/AIDS data are as of July 1, 2012, and
all STD data are as of September 1, 2012. 
I. HIV/AIDS Exposure Mode Definitions
The HIV/AIDS exposure mode indicates the most probable risk behavior associated with HIV infection. 
Assignment of exposure mode is done in accordance with Centers for Disease Control and Prevention
guidelines when multiple exposure modes are reported. Following is a description of the exposure mode 
categories:
• MSM (Male to Male Sex): Includes men who report sexual contact with other men, and men who report 
sexual contact with both men and women. Please note the acronym MSM is also used to refer to “men 
who have sex with men”.
• IDU (Injection Drug Use): Cases in persons who report injection drug use.
• MSM/IDU: Cases in men who report both injection drug use and sexual contact with other men.
• Heterosexual Sex: Cases in persons who report specific heterosexual sex with a person with, or at 
increased risk for, HIV infection (e.g. an injection drug user). The sub-categories for this mode of 
transmission are listed below.
- Heterosexual Sex w/ an Injection Drug User
- Heterosexual Sex w/ a person w/ HIV infection or AIDS
- Heterosexual Sex w/ Bisexual male
- Other Heterosexual Sex: Includes all other sub-categories of risk, such as heterosexual contact with a 
person infected through a blood transfusion.
• Presumed Heterosexual: Cases among females who report heterosexual sex but do not report any other 
personal risk or any knowledge of specific risk in their male sex partners. As of January 1, 2011, males 
that were previously grouped in this category are categorized as No Identified Risk. Presumed 
Heterosexual is an exposure mode category used by the Massachusetts HIV/AIDS Surveillance Program. 
The Centers for Disease Control and Prevention (CDC) categorizes these cases as No Identified Risk.
• Pediatric: Infection before the age of 13 years, including mother to child transmission through pregnancy, 
childbirth or breastfeeding and blood transfusions to children.
• NIR (No Identified Risk): Cases in persons with no reported history of exposure to HIV through any of 
the listed exposure categories. Follow-up is conducted to determine risk for those cases that are initially 
reported without a risk identified. Includes cases among men who were previously categorized as 
Presumed Heterosexual.
II. References to Newly Diagnosed HIV Infections
Due to reporting delays related to site-specific reporting issues, all HIV/AIDS data reflect HIV diagnosed
through 2010. Newly diagnosed HIV infections/cases include all persons diagnosed with HIV in 2010, 
including those who were concurrently or subsequently diagnosed with AIDS. 
III. Race/Ethnicity of STD and HIV/AIDS Cases
Race/ethnicity references to white residents and black residents represent persons who are white non-
Hispanic and black non-Hispanic, respectively. All references to Hispanic/Latino for race/ethnicity represent
persons of Hispanic/Latino heritage regardless of race. 
IV. STD Case Reports and Analyses
All information on STD cases reflect year of report and all incidence calculations represent crude rates. The
distribution of STD cases with unknown race/ethnicity has changed from previous issues of this report:
cases with unknown race/ethnicity are now removed from the analyses instead of redistributed. Due to this
change, STD incidence rates by race/ethnicity are lower for all years than previously reported. U.S. Census,
2000 data are used for denominators in STD rate calculations for the years 2002 through 2009 and U.S.
Census 2010 data are used for denominators for the years 2010 through 2011. Therefore caution should be
used in interpreting trends in rates between these two time periods.
V. Cell Suppression Methodology of STD and HIV/AIDS Data
Values less than five are suppressed for populations less than 50,000 or for unknown values. Additional 
values may be suppressed to prevent back calculation.
STD, HIV/AIDS AND VIRAL HEPATITIS CONTACT INFORMATION
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Policy Development 
and Administration
Sylvie Ratelle STD/HIV 
Prevention Training 
Center
STD/HIV/AIDS 
Surveillance and 
Epidemiology
STD Clinical Services 
STD Disease Intervention Field
Services and STD 
Partner Notification
STD Health Education, 
Training, and Prevention
Policy, Planning, 
Resource Allocation, 
Data Management, 
Capacity Building,  
Research and Evaluation
Administration and 
Finance, Personnel, 
Contracts and 
Procurement, Budget
Consumer Office
Prevention and Screening
Medical Case Management and
Health Related Support Services 
Viral Hepatitis Programs
Viral Hepatitis Surveillance and
Epidemiology
Brenda Cole (STD Division Director)
Katherine Hsu (Medical Director)
Janine Dyer (Deputy Director)
Betsey John (Director, HIV/ AIDS
and STD Surveillance)
Yuren Tang (STD 
Epidemiologist)
Katherine Hsu (Medical Director)
Barbara Coughlin (Public Health Nurse)
David Goudreau
(Field Operations Manager)
Brenda Hernandez 
(Special Projects Coordinator)
Laura Smock (IPP Coordinator)
Dawn Fukuda (Director, Office of
HIV/AIDS)
Maura Driscoll Miminos
(Interim Director of Research and
Evaluation)
Tammy Goodhue (Director of Capacity
Building and Health Communications)
Bob Carr (Deputy Bureau Director)
Ceci Dunn (Director of Operations)
Cheryl Bernard (Director of 
Administration and Finance)
Paul Goulet 
(Director of Consumer Office)
Barry Callis 
(Director of Prevention and Screening)
Linda Goldman
(Director of Client Health Services)
Daniel Church (Viral Hepatitis 
Prevention Coordinator, Division of
Epidemiology and Immunization)
Shauna Onofrey (Epidemiologist)
Kerri Barton (Epidemiologist)
BrendaCole@state.ma.us
Katherine.Hsu@state.ma.us
Janine.Dyer@state.ma.us
Betsey.John@state.ma.us
Yuren.Tang@state.ma.us
Katherine.Hsu@state.ma.us
Barbara.Coughlin@state.ma.us
David.Goudreau@state.ma.us
Brenda.Hernandez@state.ma.us
Laura.Smock@state.ma.us 
Dawn.Fukuda@state.ma.us
Maura.Miminos@state.ma.us
Tammy.Goodhue@state.ma.us
Bob.Carr@state.ma.us
Ceci.Dunn@state.ma.us
Cheryl.Bernard@state.ma.us
Paul.b.Goulet@state.ma.us
Barry.Callis@state.ma.us
Linda.Goldman@state.ma.us
Daniel.Church@state.ma.us
Shauna.Onofrey@state.ma.us
Kerri.Barton@state.ma.us
Topic Contact Email
Office of HIV/AIDS
Viral Hepatitis Program
617-983-6941
617-983-6948
617-983-6964
617-983-6570
617-983-6554
617-983-6948
413-586-7525
617-983-6835
617-983-6943
617-983-6961
617-624-5303
617-624-5324
617-624-5338
617-624-5317
617-624-5370
617-624-5355
617-624-5389
617-624-5316
617-624-5347
617-983-6830
617-983-6776
617-983-6876
Phone
Division of STD Prevention & HIV/AIDS Surveillance, and Ratelle STD/HIV Prevention Training Center
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STD, HIV/AIDS AND VIRAL HEPATITIS RESOURCES
Type of Training
STD Education, STD Partner Notification, 
and STD Reporting 
HIV/AIDS Reporting and 
Surveillance Projects
HIV/AIDS Provider Trainings
Viral Hepatitis Education
STD/HIV Diagnosis, Treatment, 
and Management
Material and Clinical Toolkits
Type of Material
STD, HIV, Viral Hepatitis Fact Sheets
HIV/AIDS Reporting for Health Care 
Providers Brochure
Viral Hepatitis Posters and Brochures
STD/HIV Diagnosis, Treatment, and 
Management Toolkits
MDPH and MDPH Funded Websites
Contact Information and Website
617-983-6940
www.mass.gov/dph/cdc/std
617-983-6560
www.mass.gov/dph/cdc/aids
617-624-5338
www.mass.gov/dph/aids 
617-983-6830
http://www.mass.gov/eohhs/gov/departments/dph/
programs/id/epidemiology/hepatitis/hepatitis-c/viral-
hepatitis-educational-materials.html 
617-983-6945
www.RatellePTC.org
Contact Information and Website
617-983-6940
http://www.mass.gov/eohhs/docs/dph/cdc/factsheets
/std-brochure.pdf 
617-983-6560
http://www.mass.gov/eohhs/gov/departments/dph/
programs/id/hivaids-surveillance/reporting/
617-983-6800
http://www.maclearinghouse.com/category/HEP.html 
617-983-9645
www.RatellePTC.org
Training
Professional training to community based organizations, local public health departments, and medical
providers can be requested and is free of charge. 
Division of STD Prevention www.mass.gov/dph/cdc/std
HIV/AIDS Bureau www.mass.gov/dph/aids
HIV/AIDS Surveillance www.mass.gov/dph/cdc/aids
Viral Hepatitis Program www.mass.gov/hepc
Sylvie Ratelle STD/HIV Prevention Training Center www.RatellePTC.org
National Websites 
Center for Disease Control and Prevention www.cdc.gov
Division of STD Prevention www.cdc.gov/std
Division of HIV/AIDS Prevention www.cdc.gov/hiv
Division of Viral Hepatitis www.cdc.gov/ncidod/diseases/hepatitis
National Network of STD/HIV Prevention 
Training Centers www.stdhivpreventiontraining.org
CDC funded viral hepatitis online training http://depts.washington.edu/hepstudy/ 
Health education materials and clinical toolkits can be requested free of charge.

